List View Detail View 351-375 of 493 items Sort by: Best Match Name Clone Applications Regulatory Status Previous 1 ... 14 15 16 ... 20 Next Product Clone Appl. Reg Cat# Size Purified anti-human CD45RA Antibody HI100 FC, CyTOF®, ICC, IHC-P, IHC-F, SB RUO 304102 100 µg ¥9,680 Purified anti-human CD45RA (Maxpar® Ready) Antibody HI100 FC, CyTOF® RUO 304143 100 µg ¥28,380 Spark Red™ 718 anti-human CD45RA Antibody HI100 FC RUO 304183 25 tests ¥25,300 304184 100 tests ¥53,900 Spark Blue™ 550 anti-human CD45RA Antibody HI100 FC RUO 304185 25 tests ¥33,000 304186 100 tests ¥77,000 Spark NIR™ 685 anti-human CD45RA Antibody HI100 FC RUO 304167 25 tests ¥36,300 304168 100 tests ¥87,780 Spark Blue™ 574 anti-human CD45RA (Flexi-Fluor™) Antibody HI100 FC RUO 285176 50 µg ¥86,680 TotalSeq™-A0063 anti-human CD45RA Antibody HI100 PG RUO 304157 10 µg ¥81,180 TotalSeq™-B0063 anti-human CD45RA Antibody HI100 PG RUO 304161 10 µg ¥81,180 TotalSeq™-Bn0063 anti-human CD45RA Antibody HI100 SB RUO 304181 10 µg ¥81,180 TotalSeq™-C0063 anti-human CD45RA Antibody HI100 PG RUO 304163 10 µg ¥81,180 TotalSeq™-D0063 anti-human CD45RA Antibody HI100 PG RUO 304175 10 µg ¥81,180 StarBright UltraViolet 795 anti-human CD45RA Antibody HI100 FC RUO 304199 25 tests ¥22,000 304198 100 tests ¥48,840 Spark UV™ 387 anti-human CD45RA Antibody HI100 FC RUO 304179 25 tests ¥36,300 304180 100 tests ¥80,080 Spark PLUS UV395™ anti-human CD45RA Antibody HI100 FC RUO 304189 25 tests ¥27,500 304190 100 tests ¥41,800 Spark PLUS V475™ anti-human CD45RA Antibody HI100 FC RUO 304194 25 tests ¥40,040 Spark Violet™ 423 anti-human CD45RA Antibody HI100 FC, IHC-P RUO 304177 25 tests ¥36,300 Brilliant Violet 421™ anti-human CD45RA Antibody HI100 FC, IHC-P RUO 304129 25 tests ¥38,720 Brilliant Violet 510™ anti-human CD45RA Antibody HI100 FC RUO 304141 25 tests ¥38,720 Brilliant Violet 570™ anti-human CD45RA Antibody HI100 FC RUO 304131 25 tests ¥36,320 See more size options for this product on the next page. Results Per Page: 25 50 100 200 Previous 1 ... 14 15 16 ... 20 Next
Follow Us